Velzen Pharma Private Limited

Velzen Pharma Private Limited - pharma in Hyderabad, Telangana, India. FY 2026 financials & compliance.
CIN U24239TG2022PTC161052 Incorporated 30 March 2022 ROC Hyderabad HQ Hyderabad, Telangana, India
Active Private Limited Company pharma MSME · Micro
Data last updated
Revenue · FY 2025
₹2.07 Cr
▲ 48% YoY
Net loss · FY 2025
₹71.86 Lakh
Net margin -34.7%
EBITDA · FY 2025
₹15.11 Lakh
EBITDA margin 7.3%
Authorised capital
₹2.5 Cr
Registered with MCA
Paid-up capital
₹2.5 Cr
Issued & subscribed
Open charges
₹4.95 Cr
Secured borrowings
Company age
4 yrs
Est. 2022
Directors on board
4
As per MCA filings

About Velzen Pharma Private Limited

Data last updated:

Velzen Pharma Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 30 March 2022.

The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24239TG2022PTC161052. Its GSTIN is 36AAICV6369C1Z2 (Telangana).

The company has an authorised share capital of ₹2.5 Cr and a paid-up capital of ₹2.5 Cr. It is led by directors including Kirankumar Velaveni and Sanjay Verma.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Plot No.4C Mn Sc & Tech Biotech Park Genome Valley Turkapally Shamirpet, Hyderabad, Telangana, India – 500101.

As per the financials filed for FY 2025, the company reported a revenue of ₹2.07 Cr, a growth of 48% compared to the previous year. For the same year it recorded a net loss of ₹71.86 Lakh (net margin -34.7%) and EBITDA of ₹15.11 Lakh (EBITDA margin 7.3%).

As per MCA filings, the company has open charges of ₹4.95 Cr on record.

Velzen Pharma Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-TS-20-0045512).

Company details

CIN U24239TG2022PTC161052
Registration Number 161052
Incorporation Date 30 March 2022
ROC Hyderabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
MSME Classification Micro
Udyam Registration UDYAM-TS-20-0045512
Key People
Kirankumar Velaveni Director Sanjay Verma Director Anasuya Panyala Director

Recognitions & Rankings of Velzen Pharma

MSME (Udyam registered) Ministry of MSME
Category
Micro (2022-23)
Udyam number
UDYAM-TS-20-0045512

Contact details

Velzen Pharma Private Limited's registered office is in Hyderabad, Telangana. Its e-mail address is in the company report.

  • Email
  • Registered Address
    Plot No.4C Mn Sc & Tech Biotech Park Genome Valley Turkapally Shamirpet, Hyderabad, Telangana, India – 500101
  • Industry
    Pharma, Drug Formulation & Development

To see the full contact details of Velzen Pharma Private Limited, buy the company report.

Comprehensive company report
Velzen Pharma Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Velzen Pharma is human health and social work activities. In detail, this covers human health activities.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
QHuman health and social work activities86Human health activities

To see the full business activity and turnover split of Velzen Pharma Private Limited, buy the company report.

Financials of Velzen Pharma Private Limited

FY 2025 filings available

Velzen Pharma Private Limited reported revenue of ₹2.07 Cr (up 48% YoY) for FY 2025.

Revenue · FY 2025
₹2.07 Cr ▲ 48%
Net loss · FY 2025
₹71.86 Lakh margin -34.7%
EBITDA · FY 2025
₹15.11 Lakh margin 7.3%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 48%
EBITDA CAGR growth
1 year
▼ 34%

Revenue rose 48% in the latest year. EBITDA fell 34% in the latest year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹15.11 Lakh
Profit Before Tax
Tax Expense
Net Profit (PAT)-₹71.86 Lakh
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22
Profitability
EBITDA Margin7.3%
Net Profit Margin-34.7%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Velzen Pharma Private Limited, buy the company report.

Board of directors of Velzen Pharma Private Limited

Velzen Pharma has 4 directors on record. No former directors are listed.

Current Directors
NameDesignationAppointment DateTenureStatus
Kirankumar Velaveni
Also directs: Synthovelzen Pharma Private Limited, Cronies Pharma & Bio-Sciences Private Limited
Director18 Sep 20233 Years 1 MonthsCurrent
Sanjay VermaDirector30 Mar 20224 Years 7 MonthsCurrent
Anasuya PanyalaDirector30 Mar 20224 Years 7 MonthsCurrent
Kalpana Ravanaboina
Also directs: Cronies Pharma & Bio-Sciences Private Limited, VNH Pharmaceuticals Private Limited, VNH Life Sciences Private Limited
Director20 Sep 20233 Years 1 MonthsCurrent
View all directors

Peer comparison

Velzen Pharma Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (human health activities), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Mahika Healthcare Private Limited₹2.1 Cr (FY 2024)18.0%Mumbai, Maharashtra, India
Atdi Lab Private Limited₹2.09 Cr (FY 2025)18.0%Mumbai, Maharashtra, India
Advance Amcure Hospitals Private Limited₹2.09 Cr (FY 2025)-18.0%Jaipur, Rajasthan, India
Aarav Healthcare Services Private Limited₹2.08 Cr (FY 2025)-6.0%Mumbai, Maharashtra, India
SVVS Cal Labs Private Limited₹2.08 Cr (FY 2024)91.0%Hyderabad, Telangana, India
Velzen Pharma Private Limitedthis company₹2.07 Cr (FY 2025)-₹71.86 Lakh-34.7%48.0%Hyderabad, Telangana, India
Ajeet Bhai Shri Niwash Healthcare Private Limited₹2.06 Cr (FY 2025)-12.0%Jaipur, Rajasthan, India
DDPS Santosh Critical Care Private Limited₹2.06 Cr (FY 2025)36.0%Faridabad, Haryana, India
Kamat Hospital Private Limited₹2.06 Cr (FY 2024)-20.0%Pune, Maharashtra, India
Megha Opthalmic Centre Private Limited₹2.06 Cr (FY 2025)5.0%Burdwan, West Bengal, India
Shree Varad Vinayak Hospital and Healthcare Foundation₹2.05 Cr (FY 2025)19.0%Daund, Maharashtra, India

To see the full peer comparison of Velzen Pharma Private Limited, buy the company report.

Auditor

Velzen Pharma Private Limited is audited by Y V REDDY & ASSOCIATES for the financial year 2024.

Auditor firmFinancial yearFirm registration number
Y V REDDY & ASSOCIATESFY 2024265405

Shareholding

The shareholding of Velzen Pharma Private Limited is on record for 2 financial years, the latest being FY 2024, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2024FY 2023
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Velzen Pharma Private Limited, buy the company report.

Charges & borrowings

Open charges
₹4.95 Cr
Satisfied charges
None
Breakdown by lending institutions
State Bank of India₹4.95 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
03 Oct 2023100819366State Bank of India₹4.95 CrOpen

To see the full charge records of Velzen Pharma Private Limited, buy the company report.

Total charge records: 1 View all charges

MSME payment delays

No delayed payments to MSME suppliers are on our record for Velzen Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

Employees & EPFO

Velzen Pharma Private Limited has 1 active EPFO establishment as of Sep 24, 2025.

Active EPFO establishments
1

GST

Velzen Pharma has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
36AAICV6369C1Z2TelanganaActive25 Apr 2022

To see the full GST registrations and return filing status of Velzen Pharma Private Limited, buy the company report.

Recent activity

Velzen Pharma Private Limited has 4 board changes on record since 2022: 4 appointments. The latest: Kalpana Ravanaboina was appointed as Director on 20 Sep 2023.

AGM
Velzen Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Charges
A charge with State Bank Of India of Rs. 4.95 Cr registered on 03 Oct 2023 with Charge ID 100819366 was modified on 20 Sep 2025.
Filing
Velzen Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Hyderabad.
Charges
A charge with State Bank Of India amounted to Rs. 4.95 Cr with Charge ID 100819366 was registered on 03 Oct 2023.
Appointed
Kalpana Ravanaboina was appointed as Director.
Appointed
Kirankumar Velaveni was appointed as Director.
Appointed
Anasuya Panyala was appointed as Director.
Appointed
Sanjay Verma was appointed as Director.
Incorporation
30 Mar 2022
Velzen Pharma Private Limited was registered on 30 Mar 2022 with Roc Hyderabad & aged 4 years 7 months as per MCA records.

Frequently asked questions

Velzen Pharma is an active private limited company based in Hyderabad, Telangana, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 30 March 2022 (4+ years old) and is registered under CIN U24239TG2022PTC161052.

Velzen Pharma has 4 current directors:

The latest financial statements of Velzen Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2022 are in the company report.

The GSTIN of Velzen Pharma is 36AAICV6369C1Z2, registered in Telangana.

The CIN (Corporate Identification Number) of Velzen Pharma is U24239TG2022PTC161052. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Velzen Pharma was incorporated on 30 March 2022, making it 4+ years old. It is registered with the Registrar of Companies, Hyderabad.

The peers of Velzen Pharma by revenue are Mahika Healthcare Private Limited, Atdi Lab Private Limited, Advance Amcure Hospitals Private Limited, Aarav Healthcare Services Private Limited, SVVS Cal Labs Private Limited and 5 more, all in the same principal business activity (human health activities).

Kalpana Ravanaboina was appointed as Director on 20 Sep 2023. Kirankumar Velaveni was appointed as Director on 18 Sep 2023. Anasuya Panyala was appointed as Director on 30 Mar 2022. Velzen Pharma has 4 board changes on record in total.

Yes, Velzen Pharma is registered as a micro enterprise under Udyam registration (number: UDYAM-TS-20-0045512).

The registered office of Velzen Pharma is at Plot No.4C Mn Sc & Tech Biotech Park Genome Valley Turkapally Shamirpet, Hyderabad, Telangana, India – 500101.

Velzen Pharma operates in the pharma industry, in the drug formulation and development segment.